CCR Translation for This Article from HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab

Authors:
  • SMShanu Modi
    Shanu Modi
  • ASAlison Stopeck
    Alison Stopeck
  • HLHannah Linden
    Hannah Linden
  • DSDavid Solit
    David Solit
  • SCSarat Chandarlapaty
    Sarat Chandarlapaty
  • NRNeal Rosen
    Neal Rosen
  • GDGabriella D'Andrea
    Gabriella D'Andrea
  • MDMaura Dickler
    Maura Dickler
  • MMMary E. Moynahan
    Mary E. Moynahan
  • SSSteven Sugarman
    Steven Sugarman
  • WMWeining Ma
    Weining Ma
  • SPSujata Patil
    Sujata Patil

Abstract
CCR Translation for This Article from HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab